Transcriptional Effects of ApoE4: Relevance to Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular Neurobiology

• Publication date

  2017-09-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12035-017-0757-2PMID 28879423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer’s Disease

  2017cited by this paper
• Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins

  2017cited by this paper
• ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion.

  2017cited by this paper
• Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease

  2017cited by this paper
• Nuclear uptake of an amino-terminal fragment of apolipoprotein E4 promotes cell death and localizes within microglia of the Alzheimer's disease brain.

  2017cited by this paper
• Apolipoprotein E and Alzheimer’s disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins

  2017cited by this paper
• Reversal of cognitive decline in Alzheimer's disease

  2016cited by this paper
• All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase

  2016cited by this paper
• Direct Transcriptional Effects of Apolipoprotein E

  2016cited by this paper
• Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease

  2016cited by this paper
• Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation

  2016cited by this paper
• Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease

  2016cited by this paper
• Tau and neurodegenerative disease: the story so far

  2016cited by this paper
• Relative effect of APOE ε4 on neuroimaging biomarker changes across the lifespan

  2016cited by this paper
• 2016 Alzheimer's disease facts and figures

  2016cited by this paper
• Evolutionary Analysis of the B56 Gene Family of PP2A Regulatory Subunits

  2015cited by this paper
• 2015 Alzheimer's disease facts and figures

  2015cited by this paper
• Role of apolipoprotein E in neurodegenerative diseases

  2015cited by this paper
• ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation

  2015cited by this paper
• Cilostazol suppresses β‐amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1‐coupled retinoic acid receptor‐β

  2014cited by this paper
• Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice.

  2014cited by this paper
• Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.

  2014cited by this paper
• Protein phosphatase 2A dysfunction in Alzheimer’s disease

  2014cited by this paper
• SIRT1 in neurodevelopment and brain senescence.

  2014cited by this paper
• The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease

  2014cited by this paper
• Neuroprotective effects of resveratrol in Alzheimer disease pathology

  2014cited by this paper
• Small molecule SIRT1 activators for the treatment of aging and age-related diseases.

  2014cited by this paper
• The impact of the endoplasmic reticulum protein-folding environment on cancer development

  2014cited by this paper
• Exercise, APOE genotype, and the evolution of the human lifespan.

  2014cited by this paper
• Proteolytic Cleavage of Apolipoprotein E4 as the Keystone for the Heightened Risk Associated with Alzheimer’s Disease

  2013cited by this paper
• Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A.

  2013cited by this paper
• Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8

  2013cited by this paper
• Sirtuin1: A Promising Serum Protein Marker for Early Detection of Alzheimer’s Disease

  2013cited by this paper
• Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth

  2013cited by this paper
• Binding and Repressive Activities of Apolipoprotein E3 and E4 Isoforms on the Human ApoD Promoter

  2013cited by this paper
• ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions

  2013cited by this paper
• Neuroprotective Sirtuin ratio reversed by ApoE4

  2013cited by this paper
• Apolipoprotein E4 Impairs Macrophage Efferocytosis and Potentiates Apoptosis by Accelerating Endoplasmic Reticulum Stress*

  2012cited by this paper
• P4‐251: Dysphagia in individuals with Alzheimer's disease: A systematic review of the evidence

  2012cited by this paper
• Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis.

  2012cited by this paper
• PP2A and Alzheimer disease.

  2012cited by this paper
• Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects

  2012cited by this paper
• Protein phosphatases and Alzheimer's disease.

  2012cited by this paper
• Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms*♦

  2012cited by this paper
• A large study reveals no association between APOE and Parkinson's disease.

  2012cited by this paper
• Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.

  2011cited by this paper
• P3‐157: A novel microRNA interaction relevant to alzheimer's disease pathogenesis and drug target discovery: miR‐346 induces expression of amyloid precursor protein

  2011cited by this paper
• Introducing Human APOE into Aβ Transgenic Mouse Models

  2011cited by this paper
• Apolipoprotein E in Alzheimer's disease and other neurological disorders.

  2011cited by this paper
• Reduced levels of human apoE4 protein in an animal model of cognitive impairment.

  2011cited by this paper
• Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels*

  2011cited by this paper
• APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging

  2010cited by this paper
• Probing the DNA-binding affinity and specificity of designed zinc finger proteins.

  2010cited by this paper
• Apolipoprotein E epsilon 4 allele is not associated with age at onset or MMSE of Parkinson's disease in a Korean study.

  2010cited by this paper
• Origins of specificity in protein-DNA recognition.

  2010cited by this paper
• Targeting of the prion protein to the cytosol: mechanisms and consequences.

  2010cited by this paper
• Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice

  2010cited by this paper
• Prolonged endoplasmic reticulum stress promotes mislocalization of immunoglobulins to the cytoplasm.

  2010cited by this paper
• Association between APOE ε4 Allele and Vascular Dementia: The Cache County Study

  2010cited by this paper
• Activity-Dependent Neuroprotective Protein (ADNP) Expression in the Amyloid Precursor Protein/Presenilin 1 Mouse Model of Alzheimer’s Disease

  2010cited by this paper
• Acetylation of tau inhibits its degradation and contributes to tauopathy.

  2010cited by this paper
• The role of DNA shape in protein-DNA recognition

  2009cited by this paper
• Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence

  2009cited by this paper
• Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function*

  2009cited by this paper
• ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical Neurons In Vivo

  2009cited by this paper
• Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide

  2009cited by this paper
• Macrophage-Mediated Degradation of β-Amyloid via an Apolipoprotein E Isoform-Dependent Mechanism

  2009cited by this paper
• APOE genotype-specific differences in the innate immune response.

  2009cited by this paper
• Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy

  2009cited by this paper
• ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons.

  2009cited by this paper
• GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice.

  2009cited by this paper
• ApoE promotes the proteolytic degradation of Abeta.

  2008cited by this paper
• Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease.

  2008cited by this paper
• apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.

  2008cited by this paper
• Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks.

  2008cited by this paper
• PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail).

  2008cited by this paper
• Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches.

  2008cited by this paper
• APOE ε4 allele is associated with cognitive impairment in patients with multiple sclerosis

  2008cited by this paper
• Functional role of lipoprotein receptors in Alzheimer's disease.

  2008cited by this paper
• APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.

  2008cited by this paper
• The AβCs of Aβ-cleaving Proteases*

  2008cited by this paper
• APOE ε4 is associated with impaired verbal learning in patients with MS

  2007cited by this paper
• New Insights into the Roles of Metalloproteinases in Neurodegeneration and Neuroprotection

  2007cited by this paper
• Analysis of protein-DNA interactions using surface plasmon resonance.

  2007cited by this paper
• APOE epsilon4 is associated with impaired verbal learning in patients with MS.

  2007cited by this paper
• Apolipoprotein E

  2007cited by this paper
• Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper.

  2007cited by this paper
• Apolipoprotein E and Low Density Lipoprotein Receptor-related Protein Facilitate Intraneuronal Aβ42 Accumulation in Amyloid Model Mice*

  2006cited by this paper
• Characterization of COMMD protein-protein interactions in NF-kappaB signalling.

  2006cited by this paper
• Apolipoprotein E epsilon4 allele is associated with vascular dementia.

  2006cited by this paper
• NAP, a Peptide Derived from the Activity‐Dependent Neuroprotective Protein, Modulates Macrophage Function

  2006cited by this paper
• Apolipoprotein E ε4 Allele Is Associated with Vascular Dementia

  2006cited by this paper
• Characterization of COMMD protein–protein interactions in NF-κB signalling

  2006cited by this paper
• Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

  2006cited by this paper
• The association between apolipoprotein E and multiple sclerosis

  2006cited by this paper
• Apolipoprotein E is required for cell proliferation and survival in ovarian cancer.

  2005cited by this paper
• Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior.

  2005cited by this paper
• Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis

  2004cited by this paper
• Altered Expression Levels of the Protein Phosphatase 2A ABαC Enzyme Are Associated with Alzheimer Disease Pathology

  2004cited by this paper
• Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice

  2004cited by this paper

• Mitochondrial complex-derived ROS induces lysosomal dysfunction and impairs autophagic flux in human cells carrying the APOE4 allele.

  2026cites this paper
• APP-C31 pathology as a target in neurodegenerative diseases

  2026cites this paper
• Pluripotent Cells Expressing APOE4 Exhibit a Pronounced Pro-Apoptotic Phenotype Accompanied by Markers of Hyperinflammation and a Blunted NF-κB Response

  2025cites this paper
• Definitions of healthspan: a systematic review.

  2025cites this paper
• Meningeal lymphatic drainage: novel insights into central nervous system disease

  2025cites this paper
• Short-Term Changes in Depressive Symptoms Among Patients with Alzheimer’s Disease Following a Precision Medicine Intervention

  2025cites this paper
• The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms

  2025cites this paper
• Estradiol improves behavior in FAD transgenic mice that express APOE3 but not APOE4 after ovariectomy

  2024cites this paper
• ADAM10 isoforms: optimizing usage of antibodies based on protein regulation, structural features, biological activity and clinical relevance to Alzheimer's disease.

  2024cites this paper
• Navigating the Intersection: Diabetes and Alzheimer's Intertwined Relationship.

  2024cites this paper
• Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets.

  2024cites this paper
• Women and the risk of Alzheimer's disease

  2024cites this paper
• Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review

  2023cites this paper
• The link between Alzheimer disease and metabolic syndrome: A mutual relationship and long rigorous investigation.

  2023cites this paper
• Astrocytes in functional recovery following central nervous system injuries

  2023cites this paper
• Curcumin, inflammation, and neurological disorders: How are they linked?

  2023cites this paper
• Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer’s Disease

  2023cites this paper
• Apolipoprotein ɛ4-Associated Protection Against Pediatric Enteric Infections Is a Survival Advantage in Pre-Industrial Populations

  2023cites this paper
• Upregulated NF-κB pathway proteins may underlie APOE44 associated astrocyte phenotypes in sporadic Alzheimer’s disease

  2023cites this paper
• An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer’s disease

  2023cites this paper
• Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer’s Disease

  2023cites this paper
• Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies

  2023influential citation
• The Glial Aging & Senescence Hypothesis of Late-onset Alzheimer ’ s

  2022cites this paper
• Apolipoprotein E4 Effects a Distinct Transcriptomic Profile and Dendritic Arbor Characteristics in Hippocampal Neurons Cultured in vitro

  2022cites this paper
• A multi‐hit hypothesis for an APOE4‐dependent pathophysiological state

  2022cites this paper
• Predicting conversion to Alzheimer’s disease in individuals with Mild Cognitive Impairment using clinically transferable features

  2022cites this paper
• Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease

  2022cites this paper
• A new insight on feasibility of pre-, pro-, and synbiotics-based therapies in Alzheimer’s disease

  2022cites this paper
• Working Memory Training in Amnestic and Non-amnestic Patients With Mild Cognitive Impairment: Preliminary Findings From Genotype Variants on Training Effects

  2021cites this paper
• Perspectives on the Role of APOE4 as a Therapeutic Target for Alzheimer’s Disease

  2021cites this paper
• Insights into T‐cell dysfunction in Alzheimer's disease

  2021cites this paper
• Analysis of differential gene expression and transcript usage in hippocampus of Apoe null mutant mice: implications for Alzheimer's disease.

  2021cites this paper
• Exploring Relationships in Alzheimer’s APOE Transgenic Mice

  2021cites this paper
• ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline

  2021cites this paper
• How Senescent Glia Drive And Underlie Alzheimer’s Disease: A Predictive Model

  2021cites this paper
• A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer’s Disease

  2021cites this paper
• APOE4-mediated Alzheimer disease and “Vascular”—“Meningeal Lymphatic” components: towards a novel therapeutic era?

  2021cites this paper
• Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer’s Disease

  2021cites this paper
• Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer’s Disease Mice

  2021cites this paper
• Curcumin Reduces Cognitive Deficits by Inhibiting Neuroinflammation through the Endoplasmic Reticulum Stress Pathway in Apolipoprotein E4 Transgenic Mice

  2021cites this paper
• APOE signaling in neurodegenerative diseases: an integrative approach targeting APOE coding and noncoding variants for disease intervention.

  2021cites this paper
• C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer’s disease

  2020cites this paper
• Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer’s disease

  2020cites this paper
• The Links between Cardiovascular Diseases and Alzheimer's Disease

  2020cites this paper
• APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease

  2020cites this paper
• Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease

  2020cites this paper
• Depressive and Cognitive Disorders in Climacteric Women

  2020cites this paper
• The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau

  2019cites this paper
• ApoE4: an emerging therapeutic target for Alzheimer’s disease

  2019cites this paper
• Nutrition, Inflammation, and Infection in the Genomics of Lifespan

  2019cites this paper
• Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer’s Disease

  2019cites this paper
• Sex differences in gene expression patterns associated with the APOE4 allele

  2019cites this paper
• The Role of Apolipoprotein E Isoforms in Alzheimer’s Disease

  2019cites this paper
• Genomics of Aging and Longevity

  2019cites this paper
• Inflammation in Alzheimer’s Disease: Do Sex and APOE Matter?

  2019cites this paper
• Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer’s Disease

  2018cites this paper
• Botanical Mixture Stabilizes Cognitive Function in Patients with Mild and Moderate Alzheimerâs Disease

  2018cites this paper